почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Nindanib 150 mg Capsule
Nindanib 150 mg Capsule
Manufacturer/Marketed By : Glenmark Pharmaceuticals Ltd
$11.17 $8.88
Nindanib 150 mg capsule is a powerful medication classified as a tyrosine kinase inhibitor, specifically designed for the management of idiopathic pulmonary fibrosis (IPF). This innovative treatment works by targeting...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
Nintedanib 150 mg
Active Pharmaceutical Ingredient
Nindanib 150 mg Capsule
11,17 $
8,88 $
Nindanib 150 mg capsule is a powerful medication classified as a tyrosine kinase inhibitor, specifically designed for the management of idiopathic pulmonary fibrosis (IPF). This innovative treatment works by targeting and inhibiting specific enzymes that contribute to the abnormal proliferation of lung tissue, thereby helping to slow down the progression of this debilitating disease. Patients using Nindanib may experience a reduction in lung function decline, which is crucial for maintaining quality of life. It's important to be aware of potential side effects, including gastrointestinal disturbances and liver function changes, so regular monitoring is advised during treatment. Additionally, individuals with a history of liver disease should exercise caution and consult their healthcare provider before starting this medication. As with any treatment plan, open communication with your doctor is essential to ensure the best possible outcomes while using Nindanib. Overall, Nindanib 150 mg capsules represent a significant advancement in the management of IPF, offering hope for improved lung health and better patient outcomes.
Active Pharmaceutical Ingredient
Применение
• Nindanib 150 mg capsule is primarily used for the treatment of idiopathic pulmonary fibrosis, a progressive lung disease characterized by scarring of lung tissue. This medication helps slow down the decline in lung function associated with this condition. Patients taking Nindanib 150 mg capsule may experience improved quality of life due to its effects on lung health. Regular monitoring is essential to assess the effectiveness of the treatment.
• In addition to idiopathic pulmonary fibrosis, Nindanib 150 mg capsule is indicated for certain types of interstitial lung diseases. These conditions often lead to inflammation and fibrosis, impacting respiratory function. Nindanib works by targeting specific pathways involved in these processes, thereby helping to manage symptoms. Patients with interstitial lung disease may benefit from the use of Nindanib as part of their treatment plan.
• Nindanib 150 mg capsule is also utilized in the management of non-small cell lung cancer (NSCLC). It is particularly beneficial for patients with advanced stages of this cancer, as it helps inhibit tumor growth. By targeting specific molecular pathways, Nindanib can contribute to the overall treatment strategy for NSCLC. Oncologists may prescribe this medication to enhance therapeutic outcomes for their patients.
• Furthermore, Nindanib 150 mg capsule is indicated for systemic sclerosis, a condition that can lead to lung involvement and other complications. By addressing the fibrotic processes associated with this disease, Nindanib may help to improve lung function and reduce symptoms. This medication plays a role in the comprehensive management of systemic sclerosis, particularly in patients experiencing pulmonary issues. Regular assessment of lung function is important for those using Nindanib in this context.
Преимущества
Idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis is a lung disease in which lung tissue becomes thick and stiff, eventually forming scar tissue in the lungs. The scarring, or fibrosis, appears to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible, and the first symptoms may be shortness of breath or a dry cough. Nindanib 150 mg Bottle kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. It is possible that you may experience some unpleasant side effects. Discuss this together along with your physician when you have any concerns. Interstitial lung disease: Interstitial lung disease (ILD) refers to a group of lung diseases that affect the interstitium, which is the tissue and space around the air sacs in the lungs. These conditions cause inflammation and scarring of the lung tissue, leading to difficulty in breathing. Nintedanib Capsule 150 mg kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. You may additionally experience some unpleasant side effects. If you've got any concerns, please speak them together along with your doctor. Non-small cell lung cancer (NSCLC) Non-small cell lung cancer is one of the main types of lung cancer and affects both smokers and non-smokers. Nindanib 150 mg helps treat NSCLC and can be given alone or in combination with other medicines. It is a strong and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol during this treatment and drink plenty of water to stay hydrated. Systemic sclerosis: Systemic sclerosis, commonly known as scleroderma, is an autoimmune disease that can affect various parts of the body, including the skin and internal organs. By reducing the progression of fibrosis, Nindanib Capsule may help to maintain or preserve lung function, leading to better lung capacity and potentially slowing the decline in lung function.
Побочные эффекты
Like all medicines, Nindanib 150 mg Bottle may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Наиболее распространенные побочные эффекты
• Nausea
• Vomiting
• Diarrhoea
• Stomach upset
• Loss of appetite
• Weight loss
• Fatigue
• Headache
• Unhealed wound
Распространенные побочные эффекты
• Altered blood pressure
• Liver problems (jaundice)
• Dark brown urine
• Yellowing of the skin
• Lack of energy
• Shortness of breath
• Numbness or weakness
• Difficulty in speech
• Malena ( blood in stool)
Как использовать
Nindanib 150 mg Capsule is available in the form of oral capsules to be taken by mouth as prescribed by your doctor. The frequency and dosage of the medicine will be decided by your doctor depending on the severity of the disease and certain other factors and how your body responds to the treatment.
Рекомендации по безопасности
• Alcohol: It is generally not recommended to drink alcohol while taking Nindanib 150 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Nindanib 150 mg should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Nintedanib Capsule 150 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Nindanib Capsule may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Nindanib Capsule. Nindanib 150 mg Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Nindanib 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Nindanib 150 mg Capsule should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Nintedanib Capsule 150 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Nindanib Capsule may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Nindanib 150 mg Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Nindanib 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Nindanib 150 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Nindanib Capsule.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.